Nevin İlhan (Nevin Ilhan)

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Topics

Rheumatoid Arthritis

Immune Response

Top Venues

Turkish journal of medical sciences

Journal of biochemical and molecular toxicology

Beyoglu eye journal

Cutaneous and ocular toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Şehmus Pala, Remzi Atilgan, Nevin İlhan
High amniotic fluid fractalkine and MIP-1β levels are associated with intrauterine growth restriction: a prospective cohort study. Turkish journal of medical sciences 54 (1) (2023)
Şehmus Pala, Remzi Atilgan, Nevin İlhan
High amniotic fluid fractalkine and MIP-1β levels are associated with intrauterine growth restriction: a prospective cohort study. Turkish journal of medical sciences 54 (1) (2023)
Şehmus Pala, Remzi Atilgan, Nevin İlhan
High amniotic fluid fractalkine and MIP-1β levels are associated with intrauterine growth restriction: a prospective cohort study. Turkish journal of medical sciences 54 (1) (2023)
Hakan Yıldırım, Mehmet Balbaba, Murat Erdağ, Ali Dal, Mehmet Canleblebici, Nevin İlhan, Yesari Eröksüz
Investigation of effect of nintedanib in experimental uveitis model. Cutaneous and ocular toxicology 41 (1) (2021)
Burak Turgut, Kadir Mercan, Nevin İlhan, Selahattin Semih Aydogan
Evaluation of Serum Concentration of the Myokine Irisin (FNDC5) in Patients with Age-Related. Beyoglu eye journal 6 (3) (2021)
Cengiz Şanli, Remzi Atilgan, Tuncay Kuloglu, Şehmus Pala, Bilge Aydın Turk, Hasan Burak Keser, Nevin İlhan
Transient receptor potential melastatin 2 ion channel activity in ovarian hyperstimulation syndrome physiopathology Turkish journal of medical sciences 51 (2) (2021)
Nevin İlhan, Ibrahim Bektas, Solmaz Susam, Ibrahim Hanifi Özercan
Protective effects of rosmarinic acid against azoxymethane-induced colorectal cancer in rats. Journal of biochemical and molecular toxicology (2021)
Oguzhan Tatar, Necip Ilhan, Nevin İlhan, Solmaz Susam, Ibrahim Hanifi Özercan
Is there any potential anticancer effect of raloxifene and fluoxetine on DMBA-induced rat breast cancer? Journal of biochemical and molecular toxicology 33 (9) (2019)